The healthcare sector is outperforming the broader market, driven by a series of positive earnings announcements from key pharmaceutical and healthcare companies. While the wider market is experiencing a sell-off due to disappointing results from major technology firms, strong quarterly reports from companies like AstraZeneca, Regeneron, and BrightSpring Health Services are boosting investor confidence in the healthcare industry. This positive momentum is further supported by strong earnings from Merck and Eli Lilly reported late yesterday, suggesting a potential rotation into the defensive healthcare sector.